MET and cancer: c-Met is the other receptor of LECT2, and the c-Met-LECT2 protein–protein interaction (PPI) impedes MET receptor activation to inhibit vascular invasion, metastasis, proliferation, and stemness of several cancers by antagonizing different cancer activation pathways (Figure 2B) (43, 46–48).